These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 28122295)
21. Co-delivery of paclitaxel and α-tocopherol succinate by novel chitosan-based polymeric micelles for improving micellar stability and efficacious combination therapy. Emami J; Rezazadeh M; Rostami M; Hassanzadeh F; Sadeghi H; Mostafavi A; Minaiyan M; Lavasanifar A Drug Dev Ind Pharm; 2015; 41(7):1137-47. PubMed ID: 25019502 [TBL] [Abstract][Full Text] [Related]
22. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance. Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761 [TBL] [Abstract][Full Text] [Related]
23. Co-delivery of docetaxel and chloroquine via PEO-PPO-PCL/TPGS micelles for overcoming multidrug resistance. Shi C; Zhang Z; Shi J; Wang F; Luan Y Int J Pharm; 2015 Nov; 495(2):932-9. PubMed ID: 26456262 [TBL] [Abstract][Full Text] [Related]
24. Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells. Muthu MS; Kulkarni SA; Xiong J; Feng SS Int J Pharm; 2011 Dec; 421(2):332-40. PubMed ID: 22001537 [TBL] [Abstract][Full Text] [Related]
25. Encapsulation of paclitaxel into lauric acid-O-carboxymethyl chitosan-transferrin micelles for hydrophobic drug delivery and site-specific targeted delivery. Nam JP; Park SC; Kim TH; Jang JY; Choi C; Jang MK; Nah JW Int J Pharm; 2013 Nov; 457(1):124-35. PubMed ID: 24076228 [TBL] [Abstract][Full Text] [Related]
26. Copolymers of poly(lactic acid) and D-α-tocopheryl polyethylene glycol 1000 succinate-based nanomedicines: versatile multifunctional platforms for cancer diagnosis and therapy. Vijayakumar MR; Muthu MS; Singh S Expert Opin Drug Deliv; 2013 Apr; 10(4):529-43. PubMed ID: 23316695 [TBL] [Abstract][Full Text] [Related]
28. Galactosylated TPGS Micelles for Docetaxel Targeting to Hepatic Carcinoma: Development, Characterization, and Biodistribution Study. Tekchandani P; Kurmi BD; Paliwal R; Paliwal SR AAPS PharmSciTech; 2020 Jun; 21(5):174. PubMed ID: 32548786 [TBL] [Abstract][Full Text] [Related]
29. Addition of TPGS to folate-conjugated polymer micelles for selective tumor targeting. Zhao H; Yung LY J Biomed Mater Res A; 2009 Nov; 91(2):505-18. PubMed ID: 18985763 [TBL] [Abstract][Full Text] [Related]
30. Vitamin E TPGS modified liposomes enhance cellular uptake and targeted delivery of luteolin: An in vivo/in vitro evaluation. Li J; Cheng X; Chen Y; He W; Ni L; Xiong P; Wei M Int J Pharm; 2016 Oct; 512(1):262-272. PubMed ID: 27545748 [TBL] [Abstract][Full Text] [Related]
31. TPGS-chitosome as an effective oral delivery system for improving the bioavailability of Coenzyme Q10. Shao Y; Yang L; Han HK Eur J Pharm Biopharm; 2015 Jan; 89():339-46. PubMed ID: 25542680 [TBL] [Abstract][Full Text] [Related]
32. In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle. Rezazadeh M; Emami J; Hasanzadeh F; Sadeghi H; Minaiyan M; Mostafavi A; Rostami M; Lavasanifar A Drug Deliv; 2016 Jun; 23(5):1707-17. PubMed ID: 25188785 [TBL] [Abstract][Full Text] [Related]
33. Ascorbyl palmitate/d-α-tocopheryl polyethylene glycol 1000 succinate monoester mixed micelles for prolonged circulation and targeted delivery of compound K for antilung cancer therapy in vitro and in vivo. Zhang Y; Tong D; Che D; Pei B; Xia X; Yuan G; Jin X Int J Nanomedicine; 2017; 12():605-614. PubMed ID: 28144142 [TBL] [Abstract][Full Text] [Related]
34. In vivo pharmacokinetics, biodistribution and antitumor effect of paclitaxel-loaded micelles based on α-tocopherol succinate-modified chitosan. Liang N; Sun S; Hong J; Tian J; Fang L; Cui F Drug Deliv; 2016 Oct; 23(8):2651-2660. PubMed ID: 26165423 [TBL] [Abstract][Full Text] [Related]
35. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles. Zhang Z; Feng SS Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085 [TBL] [Abstract][Full Text] [Related]
36. TPGS-g-PLGA/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy. Zhang J; Li Y; Fang X; Zhou D; Wang Y; Chen M Int J Pharm; 2014 Dec; 476(1-2):185-98. PubMed ID: 25223472 [TBL] [Abstract][Full Text] [Related]
37. D-α-tocopherol polyethylene glycol 1000 succinate-based microemulsion delivery system: Stability enhancement of physicochemical properties of luteolin. Zheng Y; Zhao C; Chen B; Teng H; Ai C; Chen L Food Chem; 2023 Nov; 426():136587. PubMed ID: 37364422 [TBL] [Abstract][Full Text] [Related]
38. Fabrication, in-silico, in-vitro, and in-vivo characterization of transferrin-targeted micelles containing cisplatin and gadolinium for improved theranostic applications in lung cancer therapy. Yadav B; Chauhan M; Sonali ; Dinkar R; Shekhar S; Singh RP Eur J Pharm Biopharm; 2023 Dec; 193():44-57. PubMed ID: 37866420 [TBL] [Abstract][Full Text] [Related]
39. Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery. Wang J; Liu W; Tu Q; Wang J; Song N; Zhang Y; Nie N; Wang J Biomacromolecules; 2011 Jan; 12(1):228-34. PubMed ID: 21158381 [TBL] [Abstract][Full Text] [Related]
40. Comparison of poly(ε-caprolactone) chain lengths of poly(ε-caprolactone)-co-d-α-tocopheryl-poly(ethylene glycol) 1000 succinate nanoparticles for enhancement of quercetin delivery to SKBR3 breast cancer cells. Suksiriworapong J; Phoca K; Ngamsom S; Sripha K; Moongkarndi P; Junyaprasert VB Eur J Pharm Biopharm; 2016 Apr; 101():15-24. PubMed ID: 26802701 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]